Daniel L. Menichella
Director/Board Member presso Spybiotech Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Sumi Biswas | F | - |
Spybiotech Ltd.
 Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | 7 anni |
| Matthew Feinsod | M | - | 10 anni | |
| Eddie J. Gray | M | 64 |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | 1 anni |
| Vien Phan | M | - |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | - |
| Marily H. Rhudy | F | 76 |
Talecris Biotherapeutics Holdings Corp.
 Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | 15 anni |
| Stephen W. Potter | M | 67 | 9 anni | |
| Mark Leuchtenberger | M | 67 |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | 2 anni |
| Craig Tooman | M | 58 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | 5 anni |
| Ekaterina Smirnyagina | M | 58 |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | - |
| Ruediger Weseloh | M | - | 18 anni | |
| Kari Heerdt | F | 57 |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | 16 anni |
| Timothy M. Wright | M | 69 |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | 5 anni |
| Mark Howarth | M | - |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | 7 anni |
| Simon J Draper | M | - |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | 7 anni |
| Bernd Winterhalter | M | 65 |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | 5 anni |
| James Wong | M | - |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Alison Lawton | F | 62 | 3 anni | |
| David Parkinson | M | 73 |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | - |
| Jerald Korn | M | 45 | 3 anni | |
| Peter Kiener | M | 72 |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | 4 anni |
| Alberto R. Martinez | M | 74 |
Grifols Therapeutics, Inc.
 Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 3 anni |
| Geoffrey von Maltzahn | M | 43 | 7 anni | |
| Karl-Ludwig Kley | M | 72 | 10 anni | |
| Lafmin Morgan | M | 60 |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC.
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Friederike Rotsch | M | 51 | 18 anni | |
| John Richard Perkins | M | 53 |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC.
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 5 anni |
| R. Grady Burnett | M | 51 | 4 anni | |
| Bonnie Bassler | M | 61 | 4 anni | |
| Samuel S. Wu | M | 57 | 4 anni | |
| William Duke | M | 51 | 3 anni | |
| Bernhard R. M. Ehmer | M | 69 | 20 anni | |
| Jill Carroll | F | 48 | 1 anni | |
| Michael Bonney | M | 65 | 4 anni | |
| Ivana Magovcevic-Liebisch | M | 55 | 8 anni | |
| Matthew Emmens | M | 72 | 4 anni | |
| Lawrence E. Bullock | M | 67 | 3 anni | |
| David Guyer | M | 64 | 3 anni | |
| Johan van Hylckama Vlieg | M | 55 | 3 anni | |
| Inge Lues | M | - | - | |
| Wayne Paterson | M | 56 | 8 anni | |
| Malte Peters | M | 61 | 1 anni | |
| Frank Hsu | M | 63 |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | 1 anni |
| Thomas Rasmussen | M | - | 3 anni | |
| Alison Long | M | - | 1 anni | |
| Dimitris Voliotis | M | 61 |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | 1 anni |
| Thomas Kessler | M | 59 | - | |
| Heiner Pieper | M | - | - | |
| Thomas Caruso | M | - |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | 3 anni |
| Rajkumar Kannan | M | 61 | 9 anni | |
| Michel Cimon | M | - | 4 anni | |
| Isabel de Paoli | F | 50 | 15 anni | |
| Mark Conley | M | 62 | 2 anni | |
| Christophe Couturier | M | 58 | 12 anni | |
| Katharine Knobil | M | 60 | 3 anni | |
| Dean Mitchell | M | 68 |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | - |
| Thomas Lander | M | 71 | - | |
| Lawrence D. Stern | M | 67 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| David Smoller | M | 60 | 2 anni | |
| Jon Stonehouse | M | 63 | 4 anni | |
| Bernhard Scheuble | M | 71 | - | |
| Kenneth J. Martin | M | 70 |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | 4 anni |
| Theo Siegert | M | 77 | 13 anni | |
| Irwin Scher | M | 84 | 3 anni | |
| David S. McCullough | M | 59 | 5 anni | |
| Lothar H. Finke | M | - | 9 anni | |
| Elmar Schnee | M | 65 | 8 anni | |
| Albrecht Merck | M | 74 | 14 anni | |
| Susan Stewart | F | 64 | 4 anni | |
| Achim Schäffler | M | - | 13 anni | |
| Rolf Krebs | M | 84 | 8 anni | |
| Marek Dziki | M | 61 | 1 anni | |
| Olaf Klinger | M | 59 | 4 anni | |
| Michael Roemer | M | - | - | |
| Dorothea Wenzel | M | 55 | 17 anni | |
| John Spencer | M | 83 | 1 anni | |
| Drayton Virkler | M | - |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | - |
| Kostas Kaloulis | M | - | 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Germania | 35 | 45.45% |
| Stati Uniti | 34 | 44.16% |
| Regno Unito | 8 | 10.39% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Daniel L. Menichella
- Contatti personali
